Tearsheet
Investment Highlights Market Valuation Price Chart Business Description Interactive Breakdown Latest Trefis Analyses Better Bets vs. NUS Recent Active Movers More From Trefis Peer Financials Peer Growth & Margins Peer Valuation Peer Returns Peer Analyses FDIC Bank Data Financials Segment Financials Price Behavior Short Interest Earnings Returns History SEC Filings Insider Activity Industry Resource Links External Quote Links

Nu Skin Enterprises (NUS)

Market Price (9/17/2025): $11.71 | Market Cap: $579.0 Mil
Sector: Consumer Staples | Industry: Household Products

Nu Skin Enterprises (NUS)

Market Price (9/17/2025): $11.71
Market Cap: $579.0 Mil
Sector: Consumer Staples
Industry: Household Products

Investment Highlights

0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 19%, Dividend Yield is 2.1%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 15%, FCF Yield is 10%		 Trading close to highs
Dist 52W High is -4.7%		 Weak revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is -12%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -13%, Rev Chg QQuarterly Revenue Change % is -12%
1  Weak multi-year price returns
2Y Excs Rtn is -93%, 3Y Excs Rtn is -130%		 
0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 19%, Dividend Yield is 2.1%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 15%, FCF Yield is 10%
1 Trading close to highs
Dist 52W High is -4.7%
2 Weak multi-year price returns
2Y Excs Rtn is -93%, 3Y Excs Rtn is -130%
3 Weak revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is -12%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -13%, Rev Chg QQuarterly Revenue Change % is -12%

Market Valuation

 9/17/252024202320222021
Share Price CYE$11.71$6.75$18.59$37.99$44.13
Market Cap CYE ($ Mil)579.0335.7918.31,878.32,200.3
Total Debt ($ Mil)310.7478.2607.3520.5503.8
Total Cash ($ Mil)265.4198.0267.8278.5354.8
Enterprise Value ($ Mil)624.3813.91,525.62,398.82,704.1
Valuation Ratios     
P/S TTM0.40.20.50.90.9
P/EBIT TTM4.3-2.318.520.68.9
P/E TTM5.7-2.3112.320.117.3
Sector Ratios     
P/S TTM (Sector)0.90.90.90.91.6
P/EBIT TTM (Sector)8.38.910.09.411.6
P/E TTM (Sector)12.512.114.012.016.2
 9/17/2520242023
Share Price CYE$11.71$6.75$18.59
Market Cap CYE ($ Mil)579.0335.7918.3
Total Debt ($ Mil)310.7478.2607.3
Total Cash ($ Mil)265.4198.0267.8
Enterprise Value ($ Mil)624.3813.91,525.6
Valuation Ratios   
P/S TTM0.40.20.5
P/EBIT TTM4.3-2.318.5
P/E TTM5.7-2.3112.3
Sector Ratios   
P/S TTM (Sector)0.90.90.9
P/EBIT TTM (Sector)8.38.910.0
P/E TTM (Sector)12.512.114.0

Market Cap Chart

Business Description

Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products. Show more

Price Returns Compared

Expand for Detailed View

 202020212022202320242025Total [1]
Returns
NUS Return39%-4%-14%-51%-64%74%-64%
Peers Return96%7%-14%1%6%-19%55%
S&P 500 Return16%27%-19%24%23%12%104%

[1] Cumulative total returns since the beginning of 2020
[2] Peers: ADUS, USPH, OMI, CL, KMB. See NUS Returns vs. Peers.
[3] 2025 data is for the year up to 9/16/2025 (YTD)

Better Bets than Nu Skin Enterprises (NUS)

 NUSBetter Performance than NUS
MetricValueIndustry (Household Products)
Rev Chg LTM-11.8%UL (11.1%), CL (0.1%), KMB (-3.1%), CHD (1.1%), CLX (0.2%)
Rev Chg 3Y Avg-13.1%UL (3.4%), CL (4.2%), KMB (-2.1%), CHD (4.6%), CLX (0.0%)
Op Mgn LTM3.5%UL (14.4%), CL (21.7%), KMB (16.7%), CHD (17.8%), CLX (16.7%)
CFO/Rev LTM5.7%UL (12.4%), CL (19.6%), KMB (15.2%), CHD (17.7%), CLX (13.8%)
FCF/Rev LTM3.6%UL (12.4%), CL (16.9%), KMB (11.1%), CHD (15.3%), CLX (10.7%)
Total Yield19.5%
 NUSBetter Performance than NUS
MetricValueAll Other Sectors
Rev Chg LTM-11.8%NVDA (71.6%), MSFT (14.9%), AAPL (6.0%), GOOGL (13.1%), AMZN (10.9%)
Rev Chg 3Y Avg-13.1%NVDA (92.0%), MSFT (12.5%), AAPL (1.8%), GOOGL (10.2%), AMZN (11.3%)
Op Mgn LTM3.5%NVDA (58.1%), MSFT (45.6%), AAPL (31.9%), GOOGL (32.7%), AMZN (11.4%)
CFO/Rev LTM5.7%NVDA (46.6%), MSFT (48.3%), AAPL (26.6%), GOOGL (36.0%), AMZN (18.1%)
FCF/Rev LTM3.6%NVDA (43.6%), MSFT (25.4%), AAPL (23.5%), GOOGL (18.0%), META (30.7%)
Total Yield19.5%BABA (38.9%), TM (2104.3%), HMC (1990.4%), BIDU (66.2%), ERIC (65.2%)

Latest Trefis Analyses

TitleTopicDate
0DASHBOARDS  
1Nu Skin Enterprises vs. S&P500 CorrelationCorrelation 
2Nu Skin Enterprises Price VolatilityVolatility 
3Day 5 of Loss Streak for Nu Skin Enterprises Stock with -30% Return (vs. -37% YTD) [2/23/2024]Notification 
4Nu Skin Enterprises (NUS) Stock Has 58% Chance Of Rise In The Next One MonthChance of Rise 
5Nu Skin Enterprises (NUS) Stock Has 58% Chance Of Rise In The Next One MonthChance of Rise 
6[11/3/2022] Nu Skin Enterprises (NUS) Shares Moved -13% Today  (Extremely rare event)  
7Dates Cached For NUS  
8Nu Skin Enterprises vs. Mid Cap Stocks: Which Is A Better Investment?Investment Theme Comparisons 
9Nu Skin Enterprises vs. Beauty Stocks: Which Is A Better Investment?Investment Theme Comparisons 
10Nu Skin Enterprises vs. Out Of Favor Health Care Stocks: Which Is A Better Investment?Investment Theme Comparisons 
11ARTICLES  
12Up 8% In One Week, Can Nu Skin Enterprises Stock Continue Its Post-Earnings Rally? February 23rd, 2022
13What’s Next For Nu Skin Stock After The Recent 12% Rise Last Week? May 11th, 2021
Title
0DASHBOARDS
1Up 8% In One Week, Can Nu Skin Enterprises Stock Continue Its Post-Earnings Rally?
2What’s Next For Nu Skin Stock After The Recent 12% Rise Last Week?
3ARTICLES
4Nu Skin Enterprises vs. S&P500 Correlation
5Nu Skin Enterprises Price Volatility
6Day 5 of Loss Streak for Nu Skin Enterprises Stock with -30% Return (vs. -37% YTD) [2/23/2024]
7Nu Skin Enterprises (NUS) Stock Has 58% Chance Of Rise In The Next One Month
8Nu Skin Enterprises (NUS) Stock Has 58% Chance Of Rise In The Next One Month
9[11/3/2022] Nu Skin Enterprises (NUS) Shares Moved -13% Today  (Extremely rare event)
10Dates Cached For NUS
11Nu Skin Enterprises vs. Mid Cap Stocks: Which Is A Better Investment?
12Nu Skin Enterprises vs. Beauty Stocks: Which Is A Better Investment?
13Nu Skin Enterprises vs. Out Of Favor Health Care Stocks: Which Is A Better Investment?

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1BDSXBiodesix1313.2%-78.6%
2CLSDClearside Biomedical954.0%-74.9%
3SDOTSadot624.1%-79.4%
4WLDSWearable Devices498.0%-30.0%
5CHEKCheck-Cap285.6%154.6%
6ATCHAtlasClear275.9%-91.0%
7HSDTHelius Medical Technologies262.5%-95.6%
8OPIOffice Properties Income Trust261.7%-13.4%
9FGIFGI Industries156.8%145.2%
10AIREReAlpha Tech154.0%-56.1%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1NAKAKindly MD-81.4% 
2ATYRaTyr Pharma-79.7%-70.2%
3LGCLLucas GC-73.6%-77.1%
4EPSMEpsium Enterprise-70.1% 
5BNGOBionano Genomics-59.4%-89.7%
6FAASDigiAsia-58.5%-87.2%
7QMMMQMMM-57.5%6775.0%
8VCIGVCI Global-56.9%-99.1%
9YYGHYY-56.6%-78.5%
10XAGELongevity Health-55.5%-86.1%

1 Month Top Gainers

#TickerCompany1M RtnYTD Rtn
1PMIPicard Medical11963.5%11963.5%
2GIBOGIBO9734.4% 
3CHSNChanson International7565.0%-99.3%
4LNZALanzaTech Global7287.5%-86.0%
5QMMMQMMM3031.7%6775.0%
6OESXOrion Energy Systems1497.9%22.9%
7CURXCuranex Pharmaceuticals1401.6%1401.6%
8ENTOEntero Therapeutics565.6%117.6%
9PTNMPitanium553.2% 
10WLDSWearable Devices449.5%-30.0%

1 Month Top Losers

#TickerCompany1M RtnYTD Rtn
1CJETChijet Motor-92.2%-95.0%
2STFSStar Fashion Culture-92.2%-97.8%
3ELPWElong Power-91.6%-76.7%
4NXTTNext Technology-89.6%-95.1%
5NAKAKindly MD-89.0% 
6BINIBollinger Innovations-88.9%-100.0%
7JEM707 Cayman-88.4%-98.2%
8YAASYouxin Technology-82.5%-98.3%
9NEONNeonode-82.0%-50.2%
10NVNOenVVeno Medical-81.5%-69.8%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1BDSXBiodesix1313.2%-78.6%
2CLSDClearside Biomedical954.0%-74.9%
3SDOTSadot624.1%-79.4%
4WLDSWearable Devices498.0%-30.0%
5CHEKCheck-Cap285.6%154.6%
6ATCHAtlasClear275.9%-91.0%
7HSDTHelius Medical Technologies262.5%-95.6%
8OPIOffice Properties Income Trust261.7%-13.4%
9FGIFGI Industries156.8%145.2%
10AIREReAlpha Tech154.0%-56.1%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1NAKAKindly MD-81.4% 
2ATYRaTyr Pharma-79.7%-70.2%
3LGCLLucas GC-73.6%-77.1%
4EPSMEpsium Enterprise-70.1% 
5BNGOBionano Genomics-59.4%-89.7%
6FAASDigiAsia-58.5%-87.2%
7QMMMQMMM-57.5%6775.0%
8VCIGVCI Global-56.9%-99.1%
9YYGHYY-56.6%-78.5%
10XAGELongevity Health-55.5%-86.1%

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Nu Skin Enterprises

Financials

NUSADUSUSPHOMICLKMBMedian
NameNu Skin .Addus Ho.US Physi.Owens & .Colgate-.Kimberly. 
Mkt Price11.72108.3578.444.9681.48125.0479.96
Mkt Cap0.62.01.20.466.041.51.6
Rev LTM1,6261,2747308,73119,99918,8835,179
Op Inc LTM57116712874,3463,160202
FCF LTM599461-1663,3702,10277
FCF 3Y Avg5696631303,0282,456113
CFO LTM93100721013,9202,872101
CFO 3Y Avg107104733533,6593,221230

Growth & Margins

NUSADUSUSPHOMICLKMBMedian
NameNu Skin .Addus Ho.US Physi.Owens & .Colgate-.Kimberly. 
Rev Chg LTM-11.8%14.3%16.2%2.5%0.1%-3.1%1.3%
Rev Chg 3Y Avg-13.1%12.1%11.4%-3.6%4.2%-2.1%1.1%
Rev Chg Q-12.1%21.8%18.0%3.3%1.0%-1.6%2.1%
QoQ Delta Rev Chg LTM-3.2%5.2%4.3%0.2%0.3%-0.4%0.3%
Op Mgn LTM3.5%9.1%9.7%3.3%21.7%16.7%9.4%
Op Mgn 3Y Avg3.9%8.7%10.7%2.8%21.2%15.2%9.7%
QoQ Delta Op Mgn LTM0.5%0.1%0.2%0.1%-0.1%0.3%0.2%
CFO/Rev LTM5.7%7.9%9.8%1.2%19.6%15.2%8.9%
CFO/Rev 3Y Avg5.9%9.3%11.4%3.7%18.7%16.5%10.3%
FCF/Rev LTM3.6%7.4%8.3%-1.9%16.9%11.1%7.8%
FCF/Rev 3Y Avg3.2%8.6%9.9%1.3%15.4%12.5%9.2%

Valuation

NUSADUSUSPHOMICLKMBMedian
NameNu Skin .Addus Ho.US Physi.Owens & .Colgate-.Kimberly. 
Mkt Cap0.62.01.20.466.041.51.6
P/S0.41.51.60.03.32.21.6
P/EBIT4.316.215.0-1.315.713.714.3
P/E5.723.635.7-0.322.717.119.9
P/CFO6.219.516.63.816.814.515.5
Total Yield19.5%4.2%3.9%-315.2%7.1%9.8%5.7%
Dividend Yield2.1%0.0%1.1%0.0%2.7%4.0%1.6%
FCF Yield 3Y Avg11.8%5.4%4.6%6.1%4.2%5.4%5.4%
D/E0.50.10.35.40.10.20.2
Net D/E0.10.10.25.30.10.20.1

Returns

NUSADUSUSPHOMICLKMBMedian
NameNu Skin .Addus Ho.US Physi.Owens & .Colgate-.Kimberly. 
1M Rtn1.9%-5.9%-8.1%-12.7%-4.2%-5.0%-5.4%
3M Rtn51.6%-5.0%5.9%-34.2%-7.5%-2.1%-3.5%
6M Rtn47.9%19.1%4.2%-49.4%-7.9%-8.7%-1.9%
12M Rtn65.1%-17.9%-4.5%-69.1%-21.0%-10.0%-14.0%
3Y Rtn-64.9%17.4%7.0%-80.3%15.6%14.4%10.7%
1M Excs Rtn-0.5%-8.3%-10.5%-15.1%-6.7%-7.4%-7.9%
3M Excs Rtn38.7%-14.8%-7.5%-46.9%-18.5%-12.9%-13.9%
6M Excs Rtn27.4%-0.4%-12.7%-66.2%-25.5%-25.3%-19.0%
12M Excs Rtn41.1%-33.7%-21.3%-83.6%-39.7%-26.9%-30.3%
3Y Excs Rtn-130.0%-46.6%-55.8%-144.9%-50.3%-52.4%-54.1%

Comparison Analyses

Title
0Nu Skin Enterprises vs. Marvell Technology Group: Similar Revenue, But Marvell Technology Group Is A Better Bet
1Nu Skin Enterprises vs. Fortinet: Similar Revenue, Similar Bets
2Nu Skin Enterprises vs. Cadence Design Systems: Similar Revenue, But Nu Skin Enterprises Is A Better Bet
3Nu Skin Enterprises vs. Blackbaud: Similar Market Cap, But Blackbaud Is A Better Bet
4Nu Skin Enterprises vs. Allegiant Travel Company: Similar Market Cap, But Allegiant Travel Company Is A Better Bet
5Nu Skin Enterprises vs. Installed Building Products: Similar Market Cap, But Installed Building Products Is A Better Bet
6Nu Skin Enterprises vs Addus HomeCare: Industry Peers; Which Stock Is A Better Bet?
7Nu Skin Enterprises vs Plexus: Similar Market Cap; Which Stock Is A Better Bet?
8Nu Skin Enterprises vs Box: Similar Market Cap; Which Stock Is A Better Bet?
9Nu Skin Enterprises vs Corcept Therapeutics: Similar Market Cap; Which Stock Is A Better Bet?

Financials

$ Mil | FY: 12/312025Q22025Q12024Q42024Q32024Q22024Q12023Q42023Q32023Q22023Q12022Q42022Q3
Period End6/30/20253/31/202512/31/20249/30/20246/30/20243/31/202412/31/20239/30/20236/30/20233/31/202312/31/20229/30/2022
Filing Date8/8/20255/9/20252/14/202511/8/20248/9/20245/9/20242/15/202411/2/20238/2/20235/4/20232/16/202311/3/2022
Key Financials Quarterly            
Total Revenue386364446430439417489499500481522538
Ebitda43152-3537-1072735-96036828
Operating Income3115-718241626-2643264610
Net Income21108-368-118-17-37271157-25
EPS0.432.16-0.730.17-2.38-0.010.15-0.740.540.231.16-0.51
Key Financials TTM            
Total Revenue TTM1,6261,6791,7321,7751,8441,9051,9692,0032,0422,1022,2262,377
Ebitda TTM19746-79-8-5411312395132142175258
Operating Income TTM5750518439586888124133159186
Net Income TTM101-39-147-103-148-3959707710538
Growth Rates Quarterly            
Total Revenue Growth-12.1%-12.7%-8.8%-13.8%-12.2%-13.3%-6.5%-7.3%-10.8%-20.4%-22.4%-16.1%
EBITDA Growth140.1%466.2%-200.6%525.5%-278.7%-26.3%369.0%-131.1%-14.4%-47.4%-91.7%-67.2%
Operating Income Growth29.4%-4.7%-127.6%169.1%-44.0%-38.3%-43.1%-367.9%-17.5%-50.4%-36.5%-85.0%
Net Income Growth117.9%20271.7%-595.8%122.5%-539.8%-104.7%-87.3%-45.5%-21.5%-70.6%719.8%-151.1%
Margins Quarterly            
EBITDA Margin11.1%41.7%-8.0%8.6%-24.4%6.4%7.2%-1.7%12.0%7.6%1.4%5.2%
Operating Income Margin8.0%4.2%-1.6%4.2%5.4%3.8%5.3%-5.3%8.5%5.4%8.8%1.8%
Net Income Margin5.5%29.5%-8.1%1.9%-26.9%-0.1%1.5%-7.4%5.4%2.4%11.0%-4.7%
Cash & Debt            
Total Cash265214198238233221268250252247279308
Total Debt311301478502529557607571582499521503
Net Debt / (Cash)4587280264296336340321330252242195
Cash Flows Quarterly            
FCF from Operations3602631513545136-222628
Cash Flows TTM            
FCF from Operations TTM93109112140160144119906778108192
Returns to Shareholders Quarterly            
Dividends333333191919191919
Share Repurchases-05-0-0-0-0-013-0-01040
Return on Invested Capital (ROIC) Quarterly            
ROIC209.1%55.8%-6.4%17.2%28.9%19.0%24.0%-32.8%37.3%32.0%75.7%17.7%
Return on Invested Capital (ROIC) TTM            
ROIC TTM107.8%53.3%15.2%30.4%12.7%17.3%6.5%27.3%37.6%52.8%65.8%44.0%

Segment Financials

Revenue by Segment

$ Mil20242023202220212020
Nu Skin1,7532,0682,523  
Manufacturing181149172  
Rhyz other3540  
Core Nu Skin Adjustments-14   
Beauty   1,4921,423
Other   168134
Wellness   923863
Total1,9692,2262,6962,5822,420


Operating Income by Segment
$ Mil20242023202220212020
Nu Skin376425572  
Manufacturing12418  
Rhyz other-21-6-2  
Corporate and other-320-311-354  
Total48111234  


Price Behavior

NUS Betas & Captures as of 8/31/2025

 1M2M3M6M1Y3Y
Beta2.112.332.150.920.850.90
Up Beta3.665.204.300.830.760.87
Down Beta2.812.513.861.341.281.15
Up Capture419%222%167%110%67%20%
Bmk +ve Days10223571142415
Stock +ve Days13213059114347
Down Capture-249%-132%-40%48%62%101%
Bmk -ve Days11192754106334
Stock -ve Days8203265129393

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Short Interest

Short Interest: As Of Date8292025
Short Interest: Shares Quantity1,927,162
Short Interest: % Change Since 81520255.2%
Average Daily Volume576,249
Days-to-Cover Short Interest3.34
Basic Shares Quantity49,441,000
Short % of Basic Shares3.9%

Returns Analyses

Earnings Returns History

Expand for More

 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
8/7/20258.9%39.5%41.1%
5/8/202511.0%21.3%31.5%
2/13/202517.8%18.4%29.5%
11/7/20241.6%11.5%21.7%
8/8/2024-3.2%-5.1%-29.4%
5/8/20242.9%9.4%7.1%
2/14/2024-20.7%-29.5%-23.6%
11/1/2023-9.5%-12.0%-3.5%
...
SUMMARY STATS   
# Positive111112
# Negative131312
Median Positive8.9%9.8%15.5%
Median Negative-7.6%-8.9%-15.5%
Max Positive27.9%39.5%45.5%
Max Negative-20.7%-29.5%-44.6%

SEC Filings

Expand for More

Report DateFiling DateFiling
6302025808202510-Q 6/30/2025
3312025509202510-Q 3/31/2025
12312024214202510-K 12/31/2024
93020241108202410-Q 9/30/2024
6302024809202410-Q 6/30/2024
3312024509202410-Q 3/31/2024
12312023215202410-K 12/31/2023
93020231102202310-Q 9/30/2023
6302023802202310-Q 6/30/2023
3312023504202310-Q 3/31/2023
12312022216202310-K 12/31/2022
93020221103202210-Q 9/30/2022
6302022805202210-Q 6/30/2022
3312022505202210-Q 3/31/2022
12312021216202210-K 12/31/2021
93020211104202110-Q 9/30/2021

Insider Activity

Expand for More

 OwnerTitleFiling DateActionPriceSharesTransacted
Value		Value of
Held Shares		Form
0CAMPBELL DANIEL W 8292025Sell12.129,046109,638475,298Form
1Hatchett Steven KeithChief Product Officer5282025Buy7.546,50049,0101,221,970Form
2Battle Emma S. 2242025Sell7.731,69313,087135,507Form

External Quote Links


Prefer one of these to Trefis? Tell us why.